CELU (Celularity Inc.) Forward P/E Multiple
The projected P/E ratio for Celularity Inc. (CELU) exhibits a volatile trend, correlating with the implementation of energy-efficient storage systems and the processing of biomaterials. A high-tech plant in New Jersey with autonomous power serves as the foundation for stability. The readiness of biobanks for commercial scaling confirms the growth potential. The current level of 0.00 reflects the volume of this metric, determining the balance between price and expected earnings.
Analytical breakdowns for Celularity Inc.
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
CELU - Company Net Income|Expected Profit Celularity Inc.|CELU - Price to Earnings Ratio|Projected Price to Earnings Celularity Inc.|CELU - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celularity Inc|CELU - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Celularity|CELU - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months celularity.com|CELU - Earnings per share increase in current year|Earnings growth forecast for next year Celularity Inc.
Summary company analytics:Celularity
Fundamental asset selection requires analyzing the probabilistic expected return to determine the fair value for entering a position. This metric measures the mathematical return on investment through revenue forecasting, which is critical for Celularity Inc. (CELU) as it transitions toward the commercialization of biomaterials and reduces reliance on external financing, reflecting the dynamics of market expectations in the company's forward P/E ratio.
Competitors of Celularity Inc. (CELU)
Projected Price to Earnings ARGX (argenx)|BNTX (BioNTech Inc.) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (abivax.com)|Market Cap to Projected Earnings ADMA Corp (ADMA)|PTGX - Future Price to Earnings|immunovant.com (IMVT) - Projected Price to Earnings|Kiniksa (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols SA|Projected Price to Earnings ADPT|Forward P/E Multiple Celldex Corp|Future Price to Earnings Aurinia Pharmaceuticals (AUPH)|biocryst.com - Price to Future Earnings Ratio|Forward P/E Multiple VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Projected Price to Earnings Ratio|Pharvaris Corp - Forward P/E Multiple|AbCellera Biologics (ABCL) - Projected Price to Earnings|TRML: Forward P/E Multiple|Projected Price to Earnings Ratio precigen.com (PGEN)|Future Price to Earnings Pharming Group|Future Price to Earnings NKTR|Projected Price to Earnings UPB (Upstream Bio Corp)|Forward P/E Multiple Zenas Corp (ZBIO)|Future Price to Earnings Immunome, Inc. IMNM|gossamerbio.com - Future Price to Earnings|KalVista Pharmaceuticals, Inc. - Forward P/E Multiple|SEPN - Forward P/E Multiple|Pieris Pharmaceuticals Inc (PVLA) - Future Price to Earnings|Savara Pharma - Future Price to Earnings Multiple|RIGL (Rigel Pharmaceuticals) - Forward P/E Multiple|anaptysbio.com (ANAB) - Market Cap to Projected Earnings|Projected Price to Earnings ATXS (Astria Therapeutics, Inc.)|Market Cap to Future Earnings Ratio ENGN|RAPT Therapeutics, Inc. - Projected Price to Earnings|Aerovate Therapeutics, Inc. (JBIO) - Projected Price to Earnings Ratio|ACRS: Projected Price to Earnings|Future Price to Earnings Multiple KYTX (kyvernatx.com)|TLSA: Forward P/E Multiple|CABA - Market Cap to Projected Earnings|Future Price to Earnings Ventyx Bio|Price to Future Earnings Ratio THTX (Theratechnologies, Inc)|Forward P/E Multiple AVTX|Projected Price to Earnings eledon.com ELDN|Agenus Inc. - Projected Price to Earnings|Market Cap to Projected Earnings Climb Bio Inc. (CLYM)|Zura Bio Limited - Forward P/E Multiple|aTyr Pharmaceuticals (ATYR) - Projected Price to Earnings|ADAG: Forward P/E Multiple|Projected Price to Earnings Ratio Ikena Oncology (IMA)|Future Price to Earnings Shattuck Labs Inc|Future Price to Earnings EQ|Projected Price to Earnings CNTB (Connect Biopharma)|Forward P/E Multiple immunic-therapeutics.com (IMUX)|Future Price to Earnings Atara Bio ATRA|IFRX (InflaRx NV) - Price to Expected Earnings Ratio|X4 Pharmaceuticals, Inc. - Forward P/E Multiple|Future Price to Earnings Multiple ACET (Adicet Bio)|INMB: Forward P/E Multiple|Barinthus Biotherapeutics Corp (BRNS) - Forward P/E Multiple|Future Price to Earnings Kezar Life Sciences|SABS: Future Price to Earnings Multiple|Future Price to Earnings Akari Therapeutics Plc (AKTX)|Projected Price to Earnings enlivex.com ENLV|Forward P/E Multiple QTTB (Q32 Bio)|Forward P/E Multiple GeoVax Corp GOVX|EDSA: Projected Price to Earnings|Future Price to Earnings Multiple IBIO (ibioinc.com)|CARM: Forward P/E Multiple|XTLB - Market Cap to Projected Earnings|Future Price to Earnings Bolt Biotherapeutics Inc.|Projected Price to Earnings HCW Biologics Inc (HCWB)|Future Price to Earnings Aptevo Therapeutics (APVO)|Projected Price to Earnings AIM ImmunoTech, Inc. AIM|Aditxt, Inc. - Projected Price to Earnings|Forward P/E Multiple GRI Bio Inc GRI|XRTX - Future Price to Earnings|HIND (Vyome Therapeutics) - Price to Future Earnings Ratio|REVB: Forward P/E Multiple|Projected Price to Earnings Ratio indaptusrx.com (INDP)|SCNI (Scinai Immunotherapeutics Ltd.) - Forward P/E Multiple|Projected Price to Earnings CalciMedica Corp (CALI)|Forward P/E Multiple AFMD|ALLK - Projected Price to Earnings Ratio|Future Price to Earnings HOOKIPA Pharma HOOK|IGM Biosciences Inc. - Future Price to Earnings|ITOS: Projected Price to Earnings|OCEA - Forward P/E Multiple|TC BioPharm (Holdings) PLC (TCBP) - Future Price to Earnings|THRD (Third Harmonic Bio Inc) - Future Price to Earnings
